The CRASH-2 trial showed that a short course of tranexamic acid given within three hours of injury to adult patients with traumatic bleeding significantly reduces all cause mortality with no apparent increase in the risk of adverse thrombotic events.
1 2 As a result, tranexamic acid is now being incorporated into trauma protocols around the world.
3 4 5 Mehr
Keine Kommentare:
Kommentar veröffentlichen